Cargando…

Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)

Detalles Bibliográficos
Autores principales: Burgers, WA, Muller, TL, Kiravu, A, Naranbhai, V, Sibeko, S, Werner, L, Karim, Q Abdool, Karim, SS Abdool
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441793/
http://dx.doi.org/10.1186/1742-4690-9-S2-P225
_version_ 1782243377437212672
author Burgers, WA
Muller, TL
Kiravu, A
Naranbhai, V
Sibeko, S
Werner, L
Karim, Q Abdool
Karim, SS Abdool
author_facet Burgers, WA
Muller, TL
Kiravu, A
Naranbhai, V
Sibeko, S
Werner, L
Karim, Q Abdool
Karim, SS Abdool
author_sort Burgers, WA
collection PubMed
description
format Online
Article
Text
id pubmed-3441793
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34417932012-09-18 Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004) Burgers, WA Muller, TL Kiravu, A Naranbhai, V Sibeko, S Werner, L Karim, Q Abdool Karim, SS Abdool Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441793/ http://dx.doi.org/10.1186/1742-4690-9-S2-P225 Text en Copyright ©2012 Burgers et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Burgers, WA
Muller, TL
Kiravu, A
Naranbhai, V
Sibeko, S
Werner, L
Karim, Q Abdool
Karim, SS Abdool
Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
title Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
title_full Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
title_fullStr Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
title_full_unstemmed Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
title_short Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
title_sort infrequent, low magnitude hiv-specific t cell responses in hiv-uninfected participants in the 1% tenofovir microbicide gel trial (caprisa004)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441793/
http://dx.doi.org/10.1186/1742-4690-9-S2-P225
work_keys_str_mv AT burgerswa infrequentlowmagnitudehivspecifictcellresponsesinhivuninfectedparticipantsinthe1tenofovirmicrobicidegeltrialcaprisa004
AT mullertl infrequentlowmagnitudehivspecifictcellresponsesinhivuninfectedparticipantsinthe1tenofovirmicrobicidegeltrialcaprisa004
AT kiravua infrequentlowmagnitudehivspecifictcellresponsesinhivuninfectedparticipantsinthe1tenofovirmicrobicidegeltrialcaprisa004
AT naranbhaiv infrequentlowmagnitudehivspecifictcellresponsesinhivuninfectedparticipantsinthe1tenofovirmicrobicidegeltrialcaprisa004
AT sibekos infrequentlowmagnitudehivspecifictcellresponsesinhivuninfectedparticipantsinthe1tenofovirmicrobicidegeltrialcaprisa004
AT wernerl infrequentlowmagnitudehivspecifictcellresponsesinhivuninfectedparticipantsinthe1tenofovirmicrobicidegeltrialcaprisa004
AT karimqabdool infrequentlowmagnitudehivspecifictcellresponsesinhivuninfectedparticipantsinthe1tenofovirmicrobicidegeltrialcaprisa004
AT karimssabdool infrequentlowmagnitudehivspecifictcellresponsesinhivuninfectedparticipantsinthe1tenofovirmicrobicidegeltrialcaprisa004